Skip to main content
HRMY logo
HRMY
(NASDAQ)
Harmony Biosciences Holdings, Inc.
$34.86-- (--)
Loading... - Market loading

Harmony Biosciences Holdings (HRMY) Stock Price & Financial Analysis

Harmony Biosciences Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$34.40 - $35.84
52-Week High$40.87
52-Week Low$25.52
Open$34.54
Volume782.58K
Average Volume (3M)913.10K
Market Cap2.05B
Shares Outstanding58.78M
P/E Ratio (TTM)13.53
Forward P/E14.16
Price to Sales (P/S)2.19
Price to Book (P/B)2.16
EV/EBITDA6.96
Revenue (TTM)899.11M
Net Income (TTM)145.62M
Free Cash Flow (TTM)341.79M
EPS (TTM)$2.48
Profit Margin16.20%
Operating Margin21.08%
Return on Equity (ROE)16.00%
Debt to Equity0.23
50-Day MA$33.35
200-Day MA$32.61
52-Week Change-7.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Harmony Biosciences Holdings

What is the current stock price for HRMY?

As of the latest trading session, HRMY stock trades at $35.80. The 52-week range is $25.52–$40.87, with a day range of $34.40–$35.84.

What is the P/E ratio for HRMY?

Harmony Biosciences Holdings's trailing P/E ratio is 13.5, meaning investors pay $13.5 for every $1 of annual earnings. The forward P/E is 14.2, reflecting analyst expectations for future earnings. Harmony Biosciences Holdings operates in the Healthcare sector.

Does HRMY pay dividends?

Harmony Biosciences Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HRMY?

Based on 5 analysts, the consensus for HRMY is Buy.

What is the market cap of HRMY?

Harmony Biosciences Holdings's market capitalization is $2.10B, classifying it as a mid-cap company. Harmony Biosciences Holdings operates in the Healthcare sector within the Biotechnology industry.